BBA
Baker Bros. Advisors’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-610,970
| Closed | -$25.3M | – | 118 |
|
|
2022
Q1 | $25.3M | Hold |
610,970
| – | – | 0.15% | 46 |
|
|
2021
Q4 | $23.1M | Buy |
610,970
+71,913
| +13% | +$2.72M | 0.11% | 56 |
|
|
2021
Q3 | $17.8M | Hold |
539,057
| – | – | 0.08% | 66 |
|
|
2021
Q2 | $36.4M | Sell |
539,057
-89,357
| -14% | -$6.03M | 0.16% | 47 |
|
|
2021
Q1 | $35.6M | Sell |
628,414
-150,420
| -19% | -$8.52M | 0.15% | 52 |
|
|
2020
Q4 | $63.5M | Sell |
778,834
-180,923
| -19% | -$14.7M | 0.24% | 28 |
|
|
2020
Q3 | $68.4M | Sell |
959,757
-50,000
| -5% | -$3.56M | 0.27% | 23 |
|
|
2020
Q2 | $83.1M | Buy |
1,009,757
+120,000
| +13% | +$9.87M | 0.37% | 23 |
|
|
2020
Q1 | $52.3M | Buy |
889,757
+60,000
| +7% | +$3.53M | 0.32% | 26 |
|
|
2019
Q4 | $85.8M | Buy |
829,757
+57,471
| +7% | +$5.94M | 0.46% | 22 |
|
|
2019
Q3 | $15.6M | Hold |
772,286
| – | – | 0.11% | 42 |
|
|
2019
Q2 | $19.9M | Sell |
772,286
-427,714
| -36% | -$11M | 0.14% | 39 |
|
|
2019
Q1 | $17.1M | Buy |
+1,200,000
| New | +$17.1M | 0.11% | 39 |
|